HALO
Halozyme Therape (HALO)
NASDAQ
$76.36+$0.25 (+0.33%)
Price as of Jul 14, 2026 4:29 AM EDT
  • $9.0B
    Market Cap
  • 32.02%
    1-Year Change
  • Biotechnology
    Industry
HALO
vs History
vs S&P 500
General Statistics
Latest Close
$76.11
Change
-$0.09 (-0.12%)
Open
$75.94
High
$76.99
Low
$74.52
Previous Close
$76.20
Volume
1,822,560
30-Day Average Volume
2,037,358
1-Week Change
-5.78%
1-Month Change
9.51%
1-Year Change
32.02%
3-Year Change
94.11%
5-Year Change
69.51%
Fundamentals
Shares Outstanding
118.6M
Total Assets
$2.7B
Market Cap
$9.0B
Enterprise Value
$10.9B
Period:
QTR
TTM
FY
Revenue
$240.7M
Net Income
$150.0M
Free Cash Flow
$176.3M
EBIT
$180.7M
EBITDA
$210.2M
Net Working Capital
$639.8M
EPS
$1.22
Enterprise Value/EBITDA
52
Enterprise Value/Revenue
45
P/B
41
P/E
62
PEG
0
Price/Free Cash Flow
51
Price/Operating Cash Flow
50
Dividends & Splits
Forward Annual Dividend Yield
N/A
Trailing Annual Dividend Yield
N/A
Ex-Dividend Date
N/A
Last Split Factor
N/A
Last Split Date
N/A

Earnings & Revenue